Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy
Summary
- Clinically important pharmacokinetic interactions between progestin injectable contraceptives and antiretrovirals have not been reported[Cohn 2007; Nanda 2008; Watts 2008; DHHS Perinatal]
- DMPA may be associated with an elevated HIV-1 RNA set point when used at the time of HIV acquisition[Lavreys 2004]
- Data suggesting an association between DMPA use and HIV acquisition or transmission are controversial, and additional studies are needed[Noguchi 2015; Polis 2013a; Polis 2013b; Polis 2013c; Lutalo 2013; Heffron 2012; Morrison 2012; McCoy 2013; Nanda 2017; ECHO 2019]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Drug-Drug Interactions, Pregnancy, Women